Corticosteroid risk function of severe infection in primary immune thrombocytopenia adults. A nationwide nested case-control study

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Moulis, Guillaume ^a,b   Palmaro, Aurore ^a,b   Sailler, Laurent ^a,b   Lapeyre Mestre, Maryse ^a,b  

^a Faculté de Médecine Centre Hospitalo universitaire   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; RITUXIMAB; PREDNISONE;

ADULT; AGE; AGED; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; FRANCE; GASTROINTESTINAL INFECTION; GENDER; HOSPITALIZATION; HUMAN; IMMUNE THROMBOCYTOPENIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; SENSITIVITY ANALYSIS; SKIN INFECTION; SPLENECTOMY; THROMBOCYTOPENIA; URINARY TRACT INFECTION; CHEMICALLY INDUCED; CLASSIFICATION; DOSE RESPONSE; INFECTION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VERY ELDERLY;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRANCE; HUMANS; INFECTION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDNISONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84955474175     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142217     Document Type: Article

References (45)

1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386-2393. doi: 10.1182/blood-2008-07-162503 PMID: 19005182
2. Lo E, Deane S. Diagnosis and classification of immune-mediated thrombocytopenia. Autoimmun Rev. 2014;13:577-583. doi: 10.1016/j.autrev. 2014.01.026 PMID: 24444701
3. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168-186. doi: 10.1182/blood-2009-06-225565 PMID: 19846889
4. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190-4207. doi: 10.1182/blood-2010-08-302984 PMID: 21325604
5. Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica. 2005;90:829-832. PMID: 15951296
6. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40. PMID: 8704187
7. Stasi R, Stipa E, Masi M, Cecconi M, Scimò MT, Oliva F, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98:436-442. PMID: 7733121
8. Moulis G, Palmaro A, Montastruc J-L, Godeau B, Lapeyre-Mestre M, Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124:3308-3315. doi: 10.1182/blood-2014-05-578336 PMID: 25305203
9. Moulis G, Lapeyre-Mestre M, Montastruc J-L, Sailler L. Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study. Autoimmun Rev. 2015;14:168-173. doi: 10. 1016/j.autrev. 2014.10.017 PMID: 25461471
10. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549-2554. PMID: 11313240
11. Nørgaard M, Jensen AØ, Engebjerg MC, Farkas DK, Thomsen RW, Cha S, et al. Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Blood. 2011;117:3514-3520. doi: 10.1182/blood-2010-10-312819 PMID: 21263148
12. Boyle S, White RH, Brunson A, Wun T. Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood. 2013;121:4782-4790. doi: 10.1182/blood-2012-12-467068 PMID: 23637127
13. Hu M-H, Yu Y-B, Huang Y-C, Gau J-P, Hsiao L-T, Liu J-H, et al. Absolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopenia. Ann Hematol. 2014;93:1023-1029. doi: 10.1007/s00277-014-2014-3 PMID: 24441917
14. Frederiksen H, Maegbaek ML, Nørgaard M. Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol. 2014;166:260-267. doi: 10.1111/bjh.12869 PMID: 24690142
15. Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, et al. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol. 2009;145:235-244. doi: 10.1111/j.1365-2141.2009.07615.x PMID: 19245432
16. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623-2634. PMID: 15217831
17. Kyaw MH, Holmes EM, Toolis F, Wayne B, Chalmers J, Jones IG, et al. Evaluation of severe infection and survival after splenectomy. Am J Med. 2006;119:276.e1-7.
18. Thomsen RW, Schoonen WM, Farkas DK, Riis A, Jacobsen J, Fryzek JP, et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med. 2009;151:546-555. PMID: 19841456
19. Cutolo M, Seriolo B, Pizzorni C, Secchi ME, Soldano S, Paolino S, et al. Use of glucocorticoids and risk of infections. Autoimmun Rev. 2008;8:153-155. doi: 10.1016/j.autrev. 2008.07.010 PMID: 18703175
20. Stasi R, Newland AC. ITP: a historical perspective. Br J Haematol. 2011;153:437-450. doi: 10.1111/j. 1365-2141.2010.08562.x PMID: 21466538
21. Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120:960-969. doi: 10.1182/blood-2011-12-309153 PMID: 22740443
22. Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood. 2008;112:999-1004. doi: 10.1182/blood-2008-01-131029 PMID: 18463354
23. Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25-33. PMID: 17200219
24. Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Derumeaux H, Adoue D. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity. Am J Hematol. 2013;89:41-6. doi: 10.1002/ajh.23580 PMID: 24038066
25. Khellaf M, Charles-Nelson A, Fain O, Terriou L, Viallard J-F, Cheze S, et al. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients. Blood. 2014;124:3228-3236. doi: 10.1182/blood-2014-06-582346 PMID: 25293768
26. Moulis G, Sailler L, Adoue D, Lapeyre-Mestre M. Pharmacoepidemiology of Immune Thrombocytopenia: protocols of FAITH and CARMEN studies. Thérapie. 2014;69:437-448. doi: 10.2515/therapie/2014056 PMID: 25285364
27. Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc J-L, Sailler L. French health insurance databases: What interest for medical research? Rev Med Interne. 2015;36:411-7 doi: 10.1016/j. revmed.2014.11.009 PMID: 25547954
28. Gottenberg J-E, Ravaud P, Bardin T, Cacoub P, Cantagrel A, Combe B, et al. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum. 2010;62:2625-2632. doi: 10.1002/art.27555 PMID: 20506353
29. Bannay A, Chaignot C, Blotière P-O, Weill A, Ricordeau P, Alla F, et al. Score de Charlson à partir des données du Sniiram chaînées au PMSI: faisabilité et valeur pronostique sur la mortalité à un an. Rev DÉpidémiologie Santé Publique. 2013; S9.
30. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716-723.
31. Grossi O, Généreau T. Glucocorticoids and. infections, doping, surgery, sexuality. Rev Med Interne. 2013;34:269-278. doi: 10.1016/j.revmed.2012.12.008 PMID: 23415059
32. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11:954.963. PMID: 2690289
33. Dixon WG, Abrahamowicz M, Beauchamp M-E, Ray DW, Bernatsky S, Suissa S, et al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis. 2012;71:1128.1133. doi: 10.1136/annrheumdis-2011-200702 PMID: 22241902
34. Dixon WG, Kezouh A, Bernatsky S, Suissa S. The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study. Ann Rheum Dis. 2011;70:956.960. doi: 10.1136/ard.2010.144741 PMID: 21285116
35. Collins AJ, Chen S-C, Gilbertson DT, Foley RN. CKD surveillance using administrative data: impact on the health care system. Am J Kidney Dis Off J Natl Kidney Found. 2009;53:S27.36.
36. Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatol Oxf Engl. 2013;52:53.61.
37. Apostolidis J, Tsandekidi M, Kousiafes D, Pagoni M, Mitsouli C, Karmiris T, et al. Short-course corticosteroidinduced pulmonary and apparent cerebral aspergillosis in a patient with idiopathic thrombocytopenic purpura. Blood. 2001;98:2875.2877.
38. Nakano T, Fukuyama S, Inoue K, Inoue H, Hagimoto N, Fujita M, et al. A case of sarcoidosis and idiopathic thrombocytopenic purpura accompanied with invasive pulmonary aspergillosis. Nihon Koky.ki Gakkai Zasshi J Jpn Respir Soc. 2002;40:945.949.
39. Tsai H-C, Lee SS-J, Wann S-R, Chen Y-S, Wang J-S, Liu Y-C. Invasive pulmonary aspergillosis with cerebral abscess in a patient with idiopathic thrombocytopenic purpura. J Chin Med Assoc JCMA. 2006;69:278.281. PMID: 16863015
40. Fianchi L, Rossi E, Murri R, De Stefano V, Pagano L, Leone G. Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura. Ann Hematol. 2007;86:225.226. PMID: 17031685
41. Papadopoulos A, Ntaios G, Kaiafa G, Girtovitis F, Charisopoulos G, Chryssogonidis I. Fatal pulmonary and cerebral aspergillosis after a short course of corticosteroids for idiopathic thrombocytopenic purpura. Ann Hematol. 2008;87:685.686. doi: 10.1007/s00277-008-0452-5 PMID: 18317759
42. Nikkels AF, Frere P, Rakic L, Fassotte M, Evrard B, De Mol P, et al. Simultaneous reactivation of herpes simplex virus and varicella-zoster virus in a patient with idiopathic thrombocytopenic purpura. Dermatol Basel Switz. 1999;199:361.364.
43. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood. 2014;123:2759.2767. doi: 10.1182/blood-2013-11-462432 PMID: 24585776
44. De Stoppelaar SF, Van'et Veer C, Claushuis TAM, Albersen BJA, Roelofs JJTH, Van Der Poll T. Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice. Blood. 2014;124:3781.3790. doi: 10.1182/blood-2014-05-573915 PMID: 25301709
45. Wu Q, Ren J, Wang G, Li G, Anjum N, Hu D, et al. Effect of Persistent Thrombocytopenia on Mortality in Surgical Critical Care Patients: A Retrospective Study. Clin Appl Thromb Off J Int Acad Clin Appl Thromb. Forthcoming 2015.